ArriVent BioPharma, Inc. (AVBP) vs Wave Life Sciences Ltd. (WVE)
A side-by-side comparison of ArriVent BioPharma, Inc. and Wave Life Sciences Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVBP
ArriVent BioPharma, Inc.
$15.09HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
WVE
Wave Life Sciences Ltd.
$3.52HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AVBP vs WVE
growth of $100 · dividends reinvested · last 3yAVBP +42.3% (+12.5%/yr)WVE -15.0% (-5.3%/yr)AVBP compounded faster over this window
AVBP WVE
AVBP vs WVE: by the numbers
- •AVBP is the larger company ($703M vs $694M market cap).
- •Both run net losses; AVBP's is the smaller (0.00% vs -309.73% net margin).
Metrics side by side
Valuation
| Metric | AVBP | WVE |
|---|---|---|
| P/S ratio | N/A | 10.61 |
| P/B ratio | 1.92 | 1.53 |
Profitability
| Metric | AVBP | WVE |
|---|---|---|
| Gross margin | 0.00% | 79.28% |
| Operating margin | 0.00% | -504.09% |
| Net margin | 0.00% | -309.73% |
| ROE | -44.63% | -44.64% |
| ROIC | -47.96% | -42.94% |
Growth (annualized)
| Metric | AVBP | WVE |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 33.08% |
| Total return CAGR (5Y) | N/A | -4.33% |
Go deeper
Dig into the metrics
ArriVent BioPharma ROEWave Life Sciences ROEArriVent BioPharma operating marginWave Life Sciences operating marginArriVent BioPharma revenue growthWave Life Sciences revenue growthArriVent BioPharma free cash flowWave Life Sciences free cash flow
ArriVent BioPharma & Wave Life Sciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.